Du L, Zong Y, Li H, Wang Q, Xie L, Yang B
Signal Transduct Target Ther. 2024; 9(1):212.
PMID: 39191722
PMC: 11350024.
DOI: 10.1038/s41392-024-01916-y.
Alhammadi N, Jan R, Alrohaily L, Aljohani S, Alharthi N, Almalki A
J Family Med Prim Care. 2024; 13(6):2266-2271.
PMID: 39027848
PMC: 11254056.
DOI: 10.4103/jfmpc.jfmpc_1393_23.
Almuqrin A, Alshuweishi Y, Alfaifi M, Daghistani H, Al-Sheikh Y, Alfhili M
Ann Saudi Med. 2024; 44(1):18-25.
PMID: 38311853
PMC: 10839458.
DOI: 10.5144/0256-4947.2024.18.
Khormi A, Basalem A, Al Muaddi A, Alaskar A, Algahtani R, Alharbi A
Immun Inflamm Dis. 2023; 11(9):e1010.
PMID: 37773706
PMC: 10540143.
DOI: 10.1002/iid3.1010.
Ghaddaf A, Alomari M, AlHarbi F, AlQuhaibi M, Alsharef J, Alsharef N
Int Orthop. 2023; 47(12):3013-3029.
PMID: 36856860
DOI: 10.1007/s00264-023-05725-w.
Prevalence of asymptomatic hyperuricemia and its association with prediabetes, dyslipidemia and subclinical inflammation markers among young healthy adults in Qatar.
Al Shanableh Y, Hussein Y, Saidwali A, Al-Mohannadi M, Aljalham B, Nurulhoque H
BMC Endocr Disord. 2022; 22(1):21.
PMID: 35031023
PMC: 8760639.
DOI: 10.1186/s12902-022-00937-4.
Risk Predictors of High Uric Acid Levels Among Patients with Type-2 Diabetes.
Eljaaly Z, Mujammami M, Nawaz S, Rafiullah M, Siddiqui K
Diabetes Metab Syndr Obes. 2022; 14:4911-4920.
PMID: 34992399
PMC: 8713713.
DOI: 10.2147/DMSO.S344894.
Prevalence of Hyperuricemia and the Use of Allopurinol in Older Poles-Results from a Population-Based PolSenior Study.
Winder M, Owczarek A, Mossakowska M, Broczek K, Grodzicki T, Wierucki L
Int J Environ Res Public Health. 2021; 18(2).
PMID: 33419128
PMC: 7825523.
DOI: 10.3390/ijerph18020387.
Geographical distribution of hyperuricemia in mainland China: a comprehensive systematic review and meta-analysis.
Huang J, Ma Z, Zhang Y, Wan Z, Li Y, Zhou H
Glob Health Res Policy. 2020; 5(1):52.
PMID: 33292806
PMC: 7708223.
DOI: 10.1186/s41256-020-00178-9.
Knowledge and practice in the management of asymptomatic hyperuricemia among primary health care physicians in Jeddah, Western Region of Saudi Arabia.
AlQarni N, Hassan A
Saudi Med J. 2018; 39(12):1218-1225.
PMID: 30520504
PMC: 6344656.
DOI: 10.15537/smj.2018.12.23715.
Risk factors analysis for hyperuricemic nephropathy among CKD stages 3-4 patients: an epidemiological study of hyperuricemia in CKD stages 3-4 patients in Ningbo, China.
Wu Y, Qiu X, Ye Y, Gao C, Wu F, Xia G
Ren Fail. 2018; 40(1):666-671.
PMID: 30489209
PMC: 6282434.
DOI: 10.1080/0886022X.2018.1487859.
Prevalence of hyperuricemia and the relationship between serum uric acid and obesity: A study on Bangladeshi adults.
Ali N, Perveen R, Rahman S, Mahmood S, Rahman S, Islam S
PLoS One. 2018; 13(11):e0206850.
PMID: 30383816
PMC: 6211757.
DOI: 10.1371/journal.pone.0206850.
Prevalence and correlates of hyperuricemia in the middle-aged and older adults in China.
Song P, Wang H, Xia W, Chang X, Wang M, An L
Sci Rep. 2018; 8(1):4314.
PMID: 29531237
PMC: 5847518.
DOI: 10.1038/s41598-018-22570-9.
Ethnopharmacological Survey of Medicinal Plants in Albaha Region, Saudi Arabia.
A Awadh Ali N, Al Sokari S, Gushash A, Anwar S, Al-Karani K, Al-Khulaidi A
Pharmacognosy Res. 2017; 9(4):401-407.
PMID: 29263636
PMC: 5717795.
DOI: 10.4103/pr.pr_11_17.
Global epidemiology of gout: prevalence, incidence and risk factors.
Kuo C, Grainge M, Zhang W, Doherty M
Nat Rev Rheumatol. 2015; 11(11):649-62.
PMID: 26150127
DOI: 10.1038/nrrheum.2015.91.
Gender impact on the correlations between subclinical thyroid dysfunction and hyperuricemia in Chinese.
Zhang J, Meng Z, Zhang Q, Liu L, Song K, Tan J
Clin Rheumatol. 2015; 35(1):143-9.
PMID: 25875744
DOI: 10.1007/s10067-015-2867-4.
Determinants of the prevalence of gout in the general population: a systematic review and meta-regression.
Wijnands J, Viechtbauer W, Thevissen K, Arts I, Dagnelie P, Stehouwer C
Eur J Epidemiol. 2014; 30(1):19-33.
PMID: 25064615
DOI: 10.1007/s10654-014-9927-y.
Prevalence of hyperuricemia among Chinese adults: a national cross-sectional survey using multistage, stratified sampling.
Liu H, Zhang X, Wang Y, Liu B
J Nephrol. 2014; 27(6):653-8.
PMID: 24687401
DOI: 10.1007/s40620-014-0082-z.
Hyperuricaemia in the Pacific: why the elevated serum urate levels?.
L Gosling A, Matisoo-Smith E, Merriman T
Rheumatol Int. 2014; 34(6):743-57.
PMID: 24378761
DOI: 10.1007/s00296-013-2922-x.
Association between Uric Acid and Metabolic Syndrome in Qazvin Metabolic Diseases Study (QMDS), Iran.
Ziaee A, Esmailzadehha N, Ghorbani A, Asefzadeh S
Glob J Health Sci. 2013; 5(1):155-65.
PMID: 23283048
PMC: 4776955.
DOI: 10.5539/gjhs.v5n1p155.